Do you want to read an article? Please log in or register.
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
Lung Cancer
RECOMMENDED
Related content
RECOMMENDED
Lung Cancer
Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study
Thorax.
Walter JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, van der Aalst CM, Yousaf-Khan U, van Ooijen PMA, Nackaerts K, Groen HJM, De Bock GH, de Koning HJ, Oudkerk M
doi: 10.1136/thoraxjnl-2018-212152.
RECOMMENDED
Lung Cancer
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
Lancet Respir Med.
Altorki NK, Wang X, Wigle , Gu L, Darling G, Ashrafi AS, Landrenau R, Miller D, Liberman M, Jones DR, Keenan R, Conti M, Wright G, Veit LJ, Ramalingam SS, Kamel M, Pass HI, Mitchell JD, Stinchcombe T, Vokes E, Kohman L
doi: 10.1016/S2213-2600
RECOMMENDED
Further Publications
Quantitative Emphysema on Low-Dose Computed Tomography of the Chest and Risk of Lung Cancer and Airflow Obstruction: An analysis of the National Lung Screening Trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Labaki WW, Xia M, Murray S, Hatt CR, Al-Abcha A, Ferrera MC, Meldrum CA, Keith LA, Galbán CJ, Arenberg DA, Curtis JL, Martinez FJ, Kazerooni EA, Han MK
doi: 10.1016/j.chest.2020.12.004
RECOMMENDED
Lung Cancer
Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial
Chest.
Whittaker Brown SA, Padilla M, Mhango G, Powell C, Salvatore M, Henschke C, Yankelevitz D, Sigel K, de-Torres JP, Wisnivesky J
doi: 10.1016/j.chest.
RECOMMENDED
Lung Cancer
Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax.
Lebrett MB, Balata H, Evison M, Colligan D, Duerden R, Elton P, Greaves M, Howells J, Irion K, Karunaratne D, Lyons J, Mellor S, Myerscough A, Newton T, Sharman A, Smith E, Taylor B, Taylor S, Walsham A, Whittaker J, Barber PV, Tonge J, Robbins HA, Booton R, Crosbie PAJ
doi: 10.1136/thoraxjnl-2020-214626.
RECOMMENDED
Lung Cancer
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Lancet Oncol.
Nestle U, Schimek-Jasch T, Kremp S, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme A, Stockinger M, Dieckmann K, Miederer M, Holl G, Rischke HC, Gkika E, Adebahr S, König J, Grosu AL, PET-Plan study group
doi: 10.1016/S1470-2045(20)30013-9.
RECOMMENDED
Lung Cancer
Patient-level trajectories and outcomes after low-dose CT screening in the National Lung Screening Trial
Chest.
Iaccarino JM, Silvestri GA, Wiener RS
doi: 10.1016/j.chest.2019.06.016.
RECOMMENDED
Lung Cancer
Protocol and Rationale for the International Lung Screening Trial (ILST)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Ann Am Thorac Soc.
Lim KP, Marshall H, Tammemägi M, Brims F, McWilliams A, Stone E, Manser R, Canfell K, Weber M, Connelly L, Bowman RV, Yang IA, Fogarty P, Mayo J, Yee J, Myers R, Atkar-Khattra S, Lam DC, Rosell A, Berg CD, Fong KM, Lam S, International Lung Screening Trial (ILST) Investigators.
doi: 10.1513/AnnalsATS.201902-102OC.
Influence of Clinical Factors and Exclusion Criteria on Mortality in ARDS Observational Studies and Randomized Controlled Trials
Respir Care.
Pais FM, Sinha P, Liu KD, Matthay MA
doi: 10.4187/respcare.06034.